Amanote Research

Amanote Research

    RegisterSign In

Revisiting Determinants of Prognosis in Cutaneous Melanoma

Cancer - United States
doi 10.1002/cncr.29634
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchOncology
Date

August 26, 2015

Authors
Sarah A. WeissDouglas HannifordEva HernandoIman Osman
Publisher

Wiley


Related search

Inflammation Markers in Cutaneous Melanoma - Edgy Biomarkers for Prognosis

Discoveries
2015English

Determinants of Survival in Patients With Brain Metastases From Cutaneous Melanoma

British Journal of Cancer
Cancer ResearchOncology
2010English

Genetic and Environmental Determinants of Immune Response to Cutaneous Melanoma

Cancer Research
Cancer ResearchOncology
2019English

Cutaneous Melanoma

British Journal of Cancer
Cancer ResearchOncology
2001English

Overexpression of SLC25A15 Is Involved in the Proliferation of Cutaneous Melanoma and Leads to Poor Prognosis

Medecine/Sciences
BiochemistryMedicineGeneticsMolecular Biology
2018English

Prognosis in Uveal Melanoma

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1948English

Overexpression of CDCA8 Promotes the Malignant Progression of Cutaneous Melanoma and Leads to Poor Prognosis

International Journal of Molecular Medicine
MedicineGenetics
2018English

Reduced Level of CD44 and Hyaluronan Associated With Unfavorable Prognosis in Clinical Stage I Cutaneous Melanoma

American Journal of Pathology
Forensic MedicinePathology
2000English

Assessing Prognosis in Uveal Melanoma

Cancer Control
MedicineOncologyHematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy